Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.

× No keyword cloud information.

19 in total

1. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort.

Authors: Rohina Rubicz; Shanshan Zhao; Craig April; Jonathan L Wright; Suzanne Kolb; Ilsa Coleman; Daniel W Lin; Peter S Nelson; Elaine A Ostrander; Ziding Feng; Jian-Bing Fan; Janet L Stanford
Journal: Prostate Date: 2015-05-18 Impact factor: 4.104

Review 2. A review of HPRT and its emerging role in cancer.

Authors: Michelle H Townsend; Richard A Robison; Kim L O'Neill
Journal: Med Oncol Date: 2018-05-05 Impact factor: 3.064

3. Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia.

Authors: Zelong Cui; Yue Fu; Zongcheng Yang; Zhenxing Gao; Huimin Feng; Minran Zhou; Lu Zhang; Chunyan Chen
Journal: Front Pharmacol Date: 2022-05-17 Impact factor: 5.988

4. Microchip immunoaffinity electrophoresis of antibody-thymidine kinase 1 complex.

Authors: Jayson V Pagaduan; Madison Ramsden; Kim O'Neill; Adam T Woolley
Journal: Electrophoresis Date: 2015-02-03 Impact factor: 3.535

5. The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.

Authors: Pengcheng Luo; Naining Wang; Ellen He; Staffan Eriksson; Ji Zhou; Guozhu Hu; Jie Zhang; Sven Skog
Journal: Pathol Oncol Res Date: 2009-12-03 Impact factor: 3.201

6. Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer.

Authors: Zhi-Heng Huang; Xing-Song Tian; Rong Li; Xian-Ming Wang; Wen Wen; Hong Guan; Ya-Jie Yang
Journal: Exp Ther Med Date: 2011-11-28 Impact factor: 2.447

7. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.

Authors: Bao-Jin Wu; Wen-Peng Li; Cheng Qian; Wei Ding; Zhong-Wen Zhou; Hua Jiang
Journal: Tumour Biol Date: 2012-11-21

8. Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.

Authors: Yanqun Xiang; Hua Zeng; Xiang Liu; Hui Zhou; Ling Luo; Chaohui Duan; Xiaohong Luo; Haiyan Yan
Journal: Biomed Rep Date: 2013-05-28

9. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.

Authors: Kiran Kumar Jagarlamudi; Lars Olof Hansson; Staffan Eriksson
Journal: BMC Cancer Date: 2015-02-18 Impact factor: 4.430

10. Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.

Authors: Lena Carlsson; Anders Larsson; Henrik Lindman
Journal: Ups J Med Sci Date: 2009 Impact factor: 2.384